[1]
Virijevic, M., Karan-Djurasevic, T., Marjanovic, I., Tosic, N., Mitrovic, M., Djunic, I., Colovic, N., Vidovic, A., Suvajdzic-Vukovic, N., Tomin, D. and Pavlovic, S. 2016. Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukemia with normal karyotype. Radiology and Oncology. 50, 4 (Nov. 2016).